New Delhi, Feb 7 (PTI) Drug firm Orchid Pharma’s standalone net loss narrowed to Rs 60.97 crore during the quarter ended December 31, 2016. Also Read - Swanky Makeover: Railway Ministry Shares Glimpses of Futuristic New Delhi Railway Station | See Photos

The company had posted a net loss of Rs 94.02 crore in the year-ago period, Orchid Pharma said in a BSE filing. Also Read - Delhi Airport's Terminal 3 Introduces New Passenger Tracking System

Its standalone total income from operations also declined to Rs 179.98 crore during the quarter under review from Rs 205.87 crore a year ago. Also Read - Why Kejriwal's Plan to Allow Hi-tech Industry is Good for Delhi

Shares of Orchid Pharma today closed 2.47 per cent down at Rs 29.65 ascrip on BSE.

This is published unedited from the PTI feed.